ID

11709

Description

The purpose of this study is to evaluate the safety of rivaroxaban in patients with recent acute coronary syndrome (ACS) and to assess the ability of rivaroxaban to reduce the occurrence of death, myocardial infarction (heart attack), repeat myocardial infarctions, stroke, and ischemia (inadequate blood supply to a local area) in patients with recent ACS. https://clinicaltrials.gov/ct2/show/NCT00402597

Link

https://clinicaltrials.gov/ct2/show/NCT00402597

Keywords

  1. 7/28/15 7/28/15 -
Uploaded on

July 28, 2015

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility ATLAS ACS TIMI 46 Acute Coronary Syndrome NCT00402597

Eligibility criteria

  1. StudyEvent: ODM
    1. Eligibility criteria
Inclusion Criteria
Description

Inclusion Criteria

Have symptoms suggestive of ACS that lasted at least 10 minutes at rest occurring within 7 days of randomization
Description

Have symptoms suggestive of ACS that lasted at least 10 minutes at rest occurring within 7 days of randomization

Data type

boolean

Alias
UMLS CUI-1
C0948089
diagnosis of ST-elevation myocardial infarction
Description

diagnosis of ST-elevation myocardial infarction

Data type

boolean

Alias
UMLS CUI-1
C1536220
diagnosis non-ST elevation myocardial infarction
Description

diagnosis non-ST elevation myocardial infarction

Data type

boolean

Alias
UMLS CUI-1
C3537184
diagnosis of unstable angina
Description

diagnosis of unstable angina

Data type

boolean

Alias
UMLS CUI-1
C0002965
Exclusion Criteria
Description

Exclusion Criteria

Active bleeding
Description

Active bleeding

Data type

boolean

Alias
UMLS CUI-1
C0019080
risk of bleeding
Description

risk of bleeding

Data type

boolean

Alias
UMLS CUI-1
C3251812
intracranial hemorrhage
Description

intracranial hemorrhage

Data type

boolean

Alias
UMLS CUI-1
C0151699
anticoagulant therapy
Description

anticoagulant therapy

Data type

boolean

Alias
UMLS CUI-1
C0150457
Significantly impaired renal function
Description

Significantly impaired renal function

Data type

boolean

Alias
UMLS CUI-1
C0035078
Significantly impaired hepatic function
Description

Significantly impaired hepatic function

Data type

boolean

Alias
UMLS CUI-1
C0085605
cardiogenic shock
Description

cardiogenic shock

Data type

boolean

Alias
UMLS CUI-1
C0036980
ventricular arrhythmias
Description

ventricular arrhythmias

Data type

boolean

Alias
UMLS CUI-1
C0085612

Similar models

Eligibility criteria

  1. StudyEvent: ODM
    1. Eligibility criteria
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Inclusion Criteria
Acute coronary syndrome
Item
Have symptoms suggestive of ACS that lasted at least 10 minutes at rest occurring within 7 days of randomization
boolean
C0948089 (UMLS CUI-1)
STEMI
Item
diagnosis of ST-elevation myocardial infarction
boolean
C1536220 (UMLS CUI-1)
NSTEMI
Item
diagnosis non-ST elevation myocardial infarction
boolean
C3537184 (UMLS CUI-1)
Unstable angina
Item
diagnosis of unstable angina
boolean
C0002965 (UMLS CUI-1)
Item Group
Exclusion Criteria
Hemorrhage
Item
Active bleeding
boolean
C0019080 (UMLS CUI-1)
Bleeding risk
Item
risk of bleeding
boolean
C3251812 (UMLS CUI-1)
intracranial hemorrhage
Item
intracranial hemorrhage
boolean
C0151699 (UMLS CUI-1)
anticoagulant therapy
Item
anticoagulant therapy
boolean
C0150457 (UMLS CUI-1)
Kidney failure
Item
Significantly impaired renal function
boolean
C0035078 (UMLS CUI-1)
Liver failure
Item
Significantly impaired hepatic function
boolean
C0085605 (UMLS CUI-1)
cardiogenic shock
Item
cardiogenic shock
boolean
C0036980 (UMLS CUI-1)
ventricular arrhythmia
Item
ventricular arrhythmias
boolean
C0085612 (UMLS CUI-1)

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial